Prevalence of and factors associated with nephropathy in diabetic patients attending an outpatient clinic in Harare, Zimbabwe

American Journal of Tropical Medicine and Hygiene

Volumn 96, Issue 2, 2017, Pages 477-482

  MacHingura, Pasipanodya Ian ^a   Chikwasha, Vasco ^a   Okwanga, Parmenas Nelson ^b   Gomo, Exnevia ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b West End Clinic   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; FRUCTOSAMINE; HEMOGLOBIN A1C; LIPID; ALBUMINOID;

ADULT; ALBUMINURIA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; FEMALE; FRUCTOSAMINE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIV TEST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; URINE LEVEL; URINE SAMPLING; ZIMBABWE; AGED; BLOOD; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; OUTPATIENT DEPARTMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ALBUMINS; ALBUMINURIA; AMBULATORY CARE FACILITIES; CREATININE; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; ZIMBABWE;

EID: 85014522151     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.15-0827     Document Type: Article

References (28)

1. Bouaziz A, Zidi I, Zidi N, Mnif W, Zinelabidine HT, 2012. Nephropathy following type 2 diabetes mellitus in Tunisian population. West Indian Med J 61: 881-889.
2. Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH, 2009. Diabetic nephropathy. Diabetol Metab Syndr 1: 10.
3. Eknoyan G, Lameire N, Eckardt KU, Kasiske BL, Wheeler DC, Levin A, Stevens PE, Bilous RW, Lamb EJ, Coresh J, 2013. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 3: 5-14.
4. Tesfaye S, Gill G, 2011. Chronic diabetic complications in Africa. Afr J Diabetes Med 19: 4-8.
5. El-Minshawy O, 2011. End stage renal disease in El-Minia Governorate, Egypt: data of the year 2007. Hypertension 200: 24.
6. Afolabi MO, Abioye-Kuteyi EA, Arogundade FA, Bello IS, 2009. Prevalence of chronic kidney disease in a Nigerian family practice population. S Afr Fam Pract 51: 132-137.
7. Janmohamed MN, Kalluvya SE, Mueller A, Kabalinga R, Smart LR, Downs JA, Peck RN, 2013. Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania. BMC Nephrol 14: 183.
8. Mafundikwa A, Ndhlovu CE, Gomo ZARG, 2007. The prevalence of diabetic nephropathy in adult patients with insulin dependent diabetes mellitus attending Parirenyatwa Diabetic Clinic Harare. Cent Afr J Med 53: 1-6.
9. The Royal College of Ophthalmologists, 2012. Diabetic Retinopathy Guidelines December 2012. London: The Royal College of Ophthalmologists.
10. Tanuja A, Guruprasad BS, Prashanth K, Prasad I, 2015. Prevalence and risk factors of diabetic retinopathy in a rural population of South India. Int J Diabetes Dev Ctries 35: 356-361.
11. Ministry of Health and Child Welfare Republic of Zimbabwe, 2011. 6th Essential Medicines List and Standard Treatment Guidelines for Zimbabwe. Zimbabwe, Harare: The National Medicine and Therapeutics Policy Advisory Committee, Ministry of Health and Child Welfare.
12. O'Connor AS, Schelling JR, 2005. Diabetes and the kidney. Am J Kidney Dis 46: 766-773.
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, Treatment of High Blood Pressure, National Heart, Lung and Blood Institute; National High Blood Pressure Education Program Coordinating Committee, 2003. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, Treatment of High Blood Pressure. Hypertension 42: 1206-1252.
14. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmerlfarb C, Handler J, Lackland DT, LeFevre ML, Mackenzie TD, Ogedegbe O, Smith SC Jr, Sveetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Ortiz E, 2014. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311: 507-520.
15. World Health Organization, 1999. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Geneva, Switzerland: World Health Organization.
16. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
17. Solimani A, Momtaz M, Shaheen N, 2012. Emergence and progression of albuminuria in a cohort of Egyptian patients with type 2 diabetes mellitus: A 5-year prospective study. Arab J Nephrol Transplant 3: 23-28.
18. Lutale JJ, Thordarson H, Abbas ZG, Vetvik K, 2007. Microalbuminuria among type 1 and type 2 diabetic patients of African origin in Dar es Salaam, Tanzania. BMC Nephrol 8: 2.
19. Bermúdez RM, Garciá SG, Surribas DP, Castelao AM, Sanjuán JB, 2011. Consensus document. Recommendations on assessing proteinuria during the diagnosis and follow-up of chronic kidney disease. Nefrologia 31: 331-345.
20. Madala ND, Thusi GP, Assounga AGH, Naicker S, 2014. Characteristics of South African patients presenting with kidney disease in rural KwaZulu-Natal: A cross sectional study. BMC Nephrol 15: 61.
21. Cohen DB, Allain JJ, Glover S, Chimbayo D, Damalala H, Hofland HWC, Banda NPK, Zijlstra EE, 2010. A Survey of the management, control, complications of diabetes mellitus in patients attending a diabetes clinic in Blantyre, Malawi, an area of high HIV prevalence. Am J Trop Med Hyg 83: 575-581.
22. Selvin E, Francis LMA, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL, Steffes MW, 2011. Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care 34: 960-967.
23. Glover SJ, Burgess PI, Cohen DB, Harding SP, Hofland HWC, Zijlstra EE, Alllain TJ, 2012. Prevalence of diabetic retinopathy, cataract and visual impairment in patients with diabetes in sub-Saharan Africa. Br J Ophthalmol 96: 156-161.
24. Onen CL, 2013. Epidemiology of ischaemic heart disease in sub-Saharan Africa : review article. Cardiovasc J Afr 24: 34-42.
25. Sowers JR, Epstein M, Frohlich ED, 2001. Diabetes, hypertension, cardiovascular disease an update. Hypertension 37: 1053-1059.
26. Chinenye S, Uloko AE, Ogbera AO, Ofoegbu EN, Fasanmade OA, Fasanmade AA, Ogbu OO, 2012. Profile of Nigerians with diabetes mellitus-Diabcare Nigeria study group (2008): results of a multicenter study. Indian J Endocrinol Metab 16: 558.
27. Ogbera AO, Fasanmade OA, Chinenye S, Akinlade A, 2009. Characterization of lipid parameters in diabetes mellitus: A Nigerian report. Int Arch Med 2: 19.
28. Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, Zafari N, Khalili D, Tohidi M, Mansournia MA, Azizi F, Hadaegh F, 2014. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: A middle eastern cohort study. PLoS One 9: e112639.